Week40, 2022
1. Influenza activity remains low nationally; 1.1% of clinical lab specimens tested positive, stable compared to the previous week.
2. Among public health labs, 86.2% of influenza-positive specimens were Influenza A, mostly H1N1; 13.8% were Influenza B, all Victoria lineage.
3. Outpatient respiratory illness visits accounted for 2.2%, remaining below the national baseline of 2.9%.
4. Week 40 cumulative hospitalization rate for influenza was 0.1 per 100,000 population, with 1,127 hospital admissions reported, slightly increasing from the prior week.
5. Deaths attributed to influenza account for 0.05% of all deaths, stable from the previous week.
6. No pediatric deaths were reported for the 2023-24 season; one pediatric death from Influenza A(H3) during the previous season was newly reported.
7. Influenza A represented 60.4% of clinical lab positive results, with Influenza B at 39.6%.
8. CDC recommends annual flu vaccination before the end of October; specific vaccination uptake data is not provided.
9. Flu activity for week 40 was predominantly minimal across jurisdictions, except one reporting moderate activity.
10. Factors like co-circulation of respiratory viruses (including RSV and SARS-CoV-2) and regional variations highlight the need for localized surveillance focus.